Variations in serum concentration of phenobarbitone in dogs receiving regular twice daily doses in relation to the times of administration

被引：13

作者：

Monteiro, R. ^{[1
]}

Anderson, T. J. ^{[1
]}

Innocent, G. ^{[1
]}

Evans, N. P. ^{[1
]}

Penderis, J. ^{[1
]}

机构：

[1] Univ Glasgow, Inst Comparat Med, Fac Vet Med, Glasgow G61 1QH, Lanark, Scotland

来源：

VETERINARY RECORD | 2009年 / 165卷 / 19期

关键词：

D O I：

10.1136/vr.165.19.556

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

The laboratory records of 1427 client-owned dogs on chronic phenobarbitone treatment were analysed. They were divided into two groups: the 918 dogs from which blood samples were collected at the trough, that is, within two hours before the next dose of phenobarbitone, and the 509 dogs from which samples were taken during the non-trough period. There were no significant differences between the mean serum concentrations of phenobarbitone in the trough and non-trough samples from dogs receiving doses ranging from 2 mg/kg per day to more than 10 mg/kg per day. However, the higher doses of phenobarbitone were associated with progressively lower phenobarbitone concentrations in the trough group relative to the non-trough group, and this difference was significant at doses of more than 10 mg/kg per day.

引用

页码：556 / 558

页数：3

共 10 条

[1]

Bielfelt S.W., Redman H.C., Mcclellan R.O., Sire-and sex-related differences in rates of epileptiform seizures in a purebred beagle dog colony, American Journal of Veterinary Research, 32, pp. 2039-2048, (1971)

[2]

Farnbach G.C., Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy, Journal of the American Veterinary Medical Association, 184, pp. 1117-1120, (1984)

[3]

Gaskill C.L., Miller L.M., Mattoon J.S., Hoffmann W.E., Burton S.A., Gelens H.C., Ihle S.L., Miller J.B., Shaw D.B., Cribb A.E., Liver histopathology and livet and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital, Veterinary Pathology, 42, pp. 147-160, (2005)

[4]

Hojo T., Ohno R., Shimoda M., Kokue E., Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosage regimen in dogs. Journal, Of Veterinary Pharmacology and Therapeutics, 25, pp. 121-127, (2002)

[5]

Levitski R.E., Trepanier L.A., Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy. Journal, Of the American Veterinary Medical Association, 217, pp. 200-204, (2000)

[6]

Muller P.B., Taboada J., Hosgood G., Partington B.P., Vansteenhouse J.L., Taylor H.W., Wolfsheimer K.J., Effects of long-term phenobarbital treatment on the liver in dogs, Journal of Veterinary Internal Medicine, 14, pp. 165-171, (2000)

[7]

O'Brien D., Pathogenesis of idiopathic epilepsy, Proceedings of the American College of Veterinary Internal Medicine Annual Forum, pp. 404-406, (2003)

[8]

Patterson E.E., Armstrong P.J., O'Brien D.P., Roberts M.C., Johnson G.S., Mickelson J.R., Clinical description and mode of inheritance of idiopathic epilepsy in english springer spaniels, Journal of the American Veterinary Medical Association, 226, pp. 54-58, (2005)

[9]

Schwartz-Porsche D., Loscher W., Frey H.H., Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: A comparison, Journal of Veterinary Pharmacology and Therapeutics, 8, pp. 113-119, (1985)

[10]

Trepanier L.A., Van Schoick A., Schwark W.S., Carrillo J., Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases ( 1992-1996), Journal of the American Veterinary Medical Association, 213, pp. 1449-1453, (1998)

← 1 →